Compare NVAX & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVAX | CUBI |
|---|---|---|
| Founded | 1987 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 2.8B |
| IPO Year | 1996 | 2010 |
| Metric | NVAX | CUBI |
|---|---|---|
| Price | $9.19 | $79.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $11.33 | ★ $85.00 |
| AVG Volume (30 Days) | ★ 5.4M | 197.2K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 309.76 | 22.99 |
| EPS | N/A | ★ 4.02 |
| Revenue | ★ $1,123,479,000.00 | N/A |
| Revenue This Year | N/A | $24.95 |
| Revenue Next Year | N/A | $9.50 |
| P/E Ratio | ★ N/A | $19.62 |
| Revenue Growth | ★ 64.69 | N/A |
| 52 Week Low | $6.20 | $59.34 |
| 52 Week High | $11.85 | $84.38 |
| Indicator | NVAX | CUBI |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 47.37 |
| Support Level | $9.14 | $74.77 |
| Resistance Level | $10.10 | $79.59 |
| Average True Range (ATR) | 0.58 | 1.68 |
| MACD | -0.04 | -0.06 |
| Stochastic Oscillator | 29.04 | 52.02 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.